DNMT1对RASSF1A甲基化的调节增强了乳腺癌的大脑转移
Qianqian Cao1, Gongwen Xu2, Guanghui Huang3
1Cancer Center, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, PR China.
Cell death & disease
|December 11, 2025
概括
DNA甲基转移酶1 (DNMT1) 通过甲基化RASSF1A.驱动乳腺癌大脑转移. 向DNMT1为转移性乳腺癌患者提供了潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 表观遗传变化,特别是DNA甲基化,在乳腺癌转移中至关重要.
- 了解推动乳腺癌大脑转移的分子机制对于有效治疗至关重要.
研究的目的:
- 研究DNA甲基转移酶1 (DNMT1) 在乳腺癌大脑转移中的作用.
- 在这个过程中阐明DNMT1和RASSF1A甲基化之间的调控关系.
主要方法:
- 循环瘤细胞 (CTC) 的单细胞转录组测序.
- DNA甲基化测序,甲基化特异性PCR和染色体免疫沉试验.
- 实地乳腺癌模型被利用.
主要成果:
- DNMT1被确定为促进瘤细胞活力,迁移和入侵的关键调节器.
- 证实RASSF1A是DNMT1介导甲基化的直接标.
- DNMT1-RASSF1A甲基化轴被验证为大脑转移的关键.
结论:
- DNMT1驱动的RASSF1A甲基化对于促进乳腺癌转移到大脑至关重要.
- 向DNMT1为治疗转移性乳腺癌提供了一个有希望的治疗途径.
更多相关视频
07:43Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
Published on: February 8, 2017
28.0K
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
23.9K
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Epigenetic Regulation
33.4K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.4K
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
lncRNA - Long Non-coding RNAs
9.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.7K
The Ras Gene
7.0K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.0K
